US drug shortages hit record high in Q1 2024, impacts cancer, ADHD drugs; Lilly, Novo ramp up production
Drug shortages are threatening healthcare systems the world over.
Be it the US, Canada, Europe or A
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Ranbaxy’s path of deception revealed in Singapore court order; Chinese, Indian, American and Spanish firms in compliance troubles
This week, Phispers brings you the
latest on the Ranbaxy-Daiichi and Merck-Gilead cases. There is al
FDA’s Drug Approvals in 2015: Novel Drugs & New Versions of Existing Drugs
Each year,
the US Food and Drug Administration (FDA) approve hundreds
of new medications. A small su
How little-known Lannett may soon become a billion-dollar generic company?
In August, when Fortune magazine
published its latest ranking of the fastest-growing companies in t